DH - Rasio rega marang pendapatan Definitive Healthcare Corp

Simbol lan logo merek Definitive Healthcare Corp (DH)

Price-to-sales dynamics help identify the gap between share price and actual revenue, where 0.60 shows the current value of the metric for Definitive Healthcare (DH). The business finances rely on the marketing expenditures of pharma behemoths and the security of cloud data. Effective management of the SaaS model, combined with growing demand for commercial analytics in medicine, ensures the stable development of Definitive Healthcare (DH).

DH Kapitalisasi marang pendapatan definitivehc.com (04.07.2022 - 13.11.2026)

Rincian analitis perusahaan Definitive Healthcare Inc. (DH)

- rega lan prakiraan konsensus rega:
Analisis umum perusahaan:DH definitivehc.com
Produk dadi Definitive Healthcare Corp.

Institutional capital assesses the investment attractiveness of Definitive Healthcare (DH) through the lens of revenue multiples, which is critical for SaaS models with subscription revenue from healthcare analytics. By analyzing the historical P/S on the GURU.Markets platform, an investor compares market capitalization with sales volume to determine the asset's degree of overvaluation and the stability of the company's cash flows amid the diversification of IT risks.

Pesaing Definitive Healthcare

Koefisien rega marang pendapatan veeva.com|Doximity - Kapitalisasi marang pendapatan|HealthEquity Inc - Rasio rega marang pendapatan|Waystar Inc. - Multiplikator P/S|Rega marang dodolan CorVel Corp.|PRVA (Privia Health Group) - Kapitalisasi marang pendapatan|huronconsultinggroup.com - Rasio kapitalisasi pasar marang pendapatan|CERT (Certara) - Multiplikator P/S|OMCL: Rasio kapitalisasi pasar marang pendapatan|Multiplikator P/S GDRX|SDGR - Rega marang dodolan|Multiplikator P/S PHR (Phreesia, Inc.)|Multiplikator P/S omadahealth.com OMDA|EVH - Rasio rega marang pendapatan|HSTM: Rasio rega marang pendapatan|CCSI (Consensus) - Kapitalisasi marang pendapatan|AGL: Kapitalisasi marang volume dodolan|ABSI (Absci) - Multiplikator P/S|SY: Rasio kapitalisasi pasar marang pendapatan|Multiplikator P/S NRC|Kapitalisasi marang pendapatan Spok Holdings Inc SPOK|Multiplikator P/S OPRX (OptimizeRx Corp.)|Multiplikator P/S TruBridge Corp TBRG|SLP - Rasio rega marang pendapatan|Rasio kapitalisasi pasar marang pendapatan SOPH (SOPHiA GENETICS SA)|HCAT: Multiplikator P/S|Rega marang dodolan CareCloud (CCLD)|RSSS (Research Solutions, Inc.) - Multiplikator P/S|Rasio kapitalisasi marang pendapatan DLHC (DLH Holdings Corp)|Multiplikator P/S ONMD|SCNX (scienture.com) - Rasio kapitalisasi pasar marang pendapatan|Multiplikator P/S HCTI (Healthcare Triangle, Inc.)|Koefisien rega marang pendapatan iSpecimen Inc (ISPC)|BFRG: Kapitalisasi marang pendapatan|SCWorx Inc - Kapitalisasi marang volume dodolan|MSPR (MSP Recovery Inc) - Kapitalisasi marang pendapatan|iCoreConnect - Rasio kapitalisasi pasar marang pendapatan|Rasio rega marang pendapatan TRxADE HEALTH|Kapitalisasi marang pendapatan Orgenesis Inc (ORGS)|Multiplikator P/S RCM|SHCR - Rega marang dodolan|Multiplikator P/S STRM (Streamline Health Solutions)|SYRA: Rasio kapitalisasi marang pendapatan|ApolloMed - Multiplikator P/S|MODN (Model N Inc) - Rasio kapitalisasi marang pendapatan|NXGN: Multiplikator P/S